Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | TGTX |
---|---|---|
09:32 ET | 15440 | 22.695 |
09:34 ET | 9806 | 22.54 |
09:36 ET | 17343 | 22.52 |
09:38 ET | 11554 | 22.625 |
09:39 ET | 4339 | 22.641 |
09:41 ET | 4631 | 22.6 |
09:43 ET | 5015 | 22.59 |
09:45 ET | 4352 | 22.61 |
09:48 ET | 3000 | 22.605 |
09:50 ET | 2930 | 22.55 |
09:52 ET | 4140 | 22.56 |
09:54 ET | 428 | 22.54 |
09:56 ET | 6623 | 22.41 |
09:57 ET | 4460 | 22.4101 |
09:59 ET | 7200 | 22.35 |
10:01 ET | 6083 | 22.42 |
10:03 ET | 2048 | 22.36 |
10:06 ET | 3901 | 22.35 |
10:08 ET | 10452 | 22.38 |
10:10 ET | 6664 | 22.27 |
10:12 ET | 2931 | 22.19 |
10:14 ET | 14903 | 22.195 |
10:15 ET | 20435 | 22.21 |
10:17 ET | 3317 | 22.285 |
10:19 ET | 1449 | 22.32 |
10:21 ET | 5200 | 22.35 |
10:24 ET | 7066 | 22.24 |
10:26 ET | 400 | 22.23 |
10:28 ET | 1800 | 22.25 |
10:30 ET | 15859 | 22.15 |
10:32 ET | 11869 | 22.14 |
10:33 ET | 5170 | 22.15 |
10:35 ET | 5040 | 22.17 |
10:37 ET | 700 | 22.17 |
10:39 ET | 8115 | 22.07 |
10:42 ET | 5058 | 22.1026 |
10:44 ET | 3515 | 22.1001 |
10:46 ET | 15191 | 22.11 |
10:48 ET | 14794 | 22.11 |
10:50 ET | 3469 | 22.07 |
10:51 ET | 1213 | 22.15 |
10:53 ET | 8000 | 22.1799 |
10:55 ET | 2563 | 22.14 |
10:57 ET | 2200 | 22.135 |
11:00 ET | 1350 | 22.15 |
11:02 ET | 2009 | 22.17 |
11:04 ET | 1800 | 22.2 |
11:06 ET | 7966 | 22.15 |
11:08 ET | 4874 | 22.16 |
11:09 ET | 6200 | 22.14 |
11:11 ET | 1600 | 22.15 |
11:13 ET | 2636 | 22.13 |
11:15 ET | 142673 | 21.86 |
11:18 ET | 5224 | 21.88 |
11:20 ET | 7916 | 21.87 |
11:22 ET | 8261 | 21.8399 |
11:24 ET | 3900 | 21.805 |
11:26 ET | 5852 | 21.85 |
11:27 ET | 3201 | 21.87 |
11:29 ET | 7621 | 21.89 |
11:31 ET | 2975 | 21.9299 |
11:33 ET | 761 | 21.935 |
11:36 ET | 8944 | 21.8201 |
11:38 ET | 2345 | 21.845 |
11:40 ET | 1907 | 21.8399 |
11:42 ET | 15112 | 21.79 |
11:44 ET | 1700 | 21.81 |
11:45 ET | 2831 | 21.8 |
11:47 ET | 21380 | 21.7703 |
11:49 ET | 4278 | 21.75 |
11:51 ET | 23366 | 21.71 |
11:54 ET | 5980 | 21.73 |
11:56 ET | 13058 | 21.76 |
11:58 ET | 25054 | 21.68 |
12:00 ET | 13663 | 21.69 |
12:02 ET | 7400 | 21.73 |
12:03 ET | 6673 | 21.705 |
12:05 ET | 6396 | 21.69 |
12:07 ET | 2742 | 21.715 |
12:09 ET | 13984 | 21.72 |
12:12 ET | 8174 | 21.72 |
12:14 ET | 8524 | 21.74 |
12:16 ET | 13720 | 21.69 |
12:18 ET | 3089 | 21.72 |
12:20 ET | 9573 | 21.74 |
12:21 ET | 7215 | 21.73 |
12:23 ET | 3327 | 21.72 |
12:25 ET | 9528 | 21.74 |
12:27 ET | 6800 | 21.795 |
12:30 ET | 8659 | 21.735 |
12:32 ET | 4853 | 21.73 |
12:34 ET | 7264 | 21.73 |
12:36 ET | 28392 | 21.785 |
12:38 ET | 79542 | 21.9199 |
12:39 ET | 26945 | 22.0501 |
12:41 ET | 25334 | 22.06 |
12:43 ET | 8918 | 22.13 |
12:45 ET | 9047 | 22.07 |
12:48 ET | 9154 | 21.97 |
12:50 ET | 22763 | 22 |
12:52 ET | 3227 | 21.98 |
12:54 ET | 4921 | 21.95 |
12:56 ET | 4100 | 21.9291 |
12:57 ET | 4150 | 21.975 |
12:59 ET | 1311 | 21.93 |
01:01 ET | 1182 | 21.945 |
01:03 ET | 8709 | 21.95 |
01:06 ET | 28545 | 22.065 |
01:08 ET | 11521 | 22.0225 |
01:10 ET | 1633 | 22 |
01:12 ET | 13683 | 22.04 |
01:14 ET | 3991 | 22.045 |
01:15 ET | 2714 | 22.065 |
01:17 ET | 13214 | 22.1 |
01:19 ET | 11715 | 22.055 |
01:21 ET | 3800 | 22.05 |
01:24 ET | 1809 | 22.01 |
01:26 ET | 2724 | 22 |
01:28 ET | 600 | 21.97 |
01:30 ET | 1047 | 21.93 |
01:32 ET | 8964 | 21.96 |
01:33 ET | 900 | 21.99 |
01:35 ET | 6131 | 21.98 |
01:37 ET | 2437 | 21.92 |
01:39 ET | 2854 | 21.9 |
01:42 ET | 2300 | 21.9 |
01:44 ET | 1115 | 21.94 |
01:46 ET | 1825 | 21.95 |
01:48 ET | 4371 | 21.95 |
01:50 ET | 3044 | 21.945 |
01:51 ET | 5958 | 21.92 |
01:53 ET | 7591 | 21.83 |
01:55 ET | 2998 | 21.85 |
01:57 ET | 1160 | 21.865 |
02:00 ET | 6799 | 21.84 |
02:02 ET | 12556 | 21.82 |
02:04 ET | 2353 | 21.85 |
02:06 ET | 10387 | 21.87 |
02:08 ET | 1300 | 21.865 |
02:09 ET | 4209 | 21.895 |
02:11 ET | 2100 | 21.895 |
02:13 ET | 4482 | 21.915 |
02:15 ET | 5335 | 21.92 |
02:18 ET | 3020 | 21.925 |
02:20 ET | 3894 | 21.95 |
02:22 ET | 1800 | 21.93 |
02:24 ET | 700 | 21.935 |
02:26 ET | 2612 | 21.965 |
02:27 ET | 6940 | 21.98 |
02:29 ET | 2500 | 21.95 |
02:31 ET | 900 | 21.9577 |
02:33 ET | 3900 | 21.935 |
02:36 ET | 2032 | 21.955 |
02:38 ET | 1067 | 21.96 |
02:40 ET | 2939 | 21.97 |
02:42 ET | 1685 | 21.99 |
02:44 ET | 3778 | 21.995 |
02:45 ET | 15601 | 21.96 |
02:47 ET | 4275 | 21.975 |
02:49 ET | 1595 | 21.975 |
02:51 ET | 20799 | 21.96 |
02:54 ET | 3190 | 21.94 |
02:56 ET | 6251 | 21.91 |
02:58 ET | 1826 | 21.935 |
03:00 ET | 3440 | 21.94 |
03:02 ET | 7146 | 21.99 |
03:03 ET | 4448 | 22.05 |
03:05 ET | 11249 | 22.1125 |
03:07 ET | 12026 | 22.23 |
03:09 ET | 11892 | 22.225 |
03:12 ET | 11949 | 22.22 |
03:14 ET | 15862 | 22.19 |
03:16 ET | 7777 | 22.225 |
03:18 ET | 12570 | 22.244 |
03:20 ET | 6269 | 22.255 |
03:21 ET | 13401 | 22.32 |
03:23 ET | 15446 | 22.315 |
03:25 ET | 9693 | 22.315 |
03:27 ET | 9494 | 22.31 |
03:30 ET | 6332 | 22.345 |
03:32 ET | 10689 | 22.289 |
03:34 ET | 19826 | 22.28 |
03:36 ET | 11507 | 22.245 |
03:38 ET | 9626 | 22.345 |
03:39 ET | 12572 | 22.35 |
03:41 ET | 7068 | 22.29 |
03:43 ET | 7363 | 22.28 |
03:45 ET | 5758 | 22.285 |
03:48 ET | 12607 | 22.23 |
03:50 ET | 3269 | 22.235 |
03:52 ET | 18465 | 22.185 |
03:54 ET | 11569 | 22.195 |
03:56 ET | 14963 | 22.24 |
03:57 ET | 13063 | 22.1713 |
03:59 ET | 229085 | 22.23 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
TG Therapeutics Inc | 3.4B | 37.0x | --- |
Axsome Therapeutics Inc | 4.2B | -13.3x | --- |
Twist Bioscience Corp | 2.5B | -11.4x | --- |
Zai Lab Ltd | 2.6B | -8.6x | --- |
Apellis Pharmaceuticals Inc | 3.3B | -10.0x | --- |
Arrowhead Pharmaceuticals Inc | 2.3B | -4.0x | --- |
TG Therapeutics, Inc. is a fully integrated, commercial stage, biopharmaceutical company. The Company is focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. Its clinical drug candidates include Ublituximab (anti-CD20 mAb), TG-1701 (BTK inhibitor) and TG-1801 (anti-CD47/CD19 bispecific mAb). BRIUMVI is an anti-CD20 monoclonal antibody for the treatment of RMS, which include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. TG-1701 is a novel, orally available and covalently bound Bruton’s tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in in vitro kinase screening. TG-1801 is a bispecific CD47 and CD19 antibody. It is the therapy to target both CD19, a B-cell specific market expressed across B-cell malignancies, and CD47. It also evaluates complementary products, technologies and companies for in-licensing, partnership, acquisition and/or investment opportunities.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.4B |
---|---|
Revenue (TTM) | $346.7M |
Shares Outstanding | 154.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.21 |
EPS | $0.60 |
Book Value | $1.06 |
P/E Ratio | 37.0x |
Price/Sales (TTM) | 9.9 |
Price/Cash Flow (TTM) | 35.9x |
Operating Margin | 29.37% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.